What is the Impact of Price Controls on Patients And

Others With a Stake in the Healthcare Debate? / Major StudyExamines Implications for Europe, Japan and the U.S. Washington, D.C. (ots-PRNewswire) - WHAT: Warner-Lambert will release findings of a study,conducted by The Boston Consulting Group (BCG), measuring theimpact of price controls on the three stakeholders in the health

care debate: patients, government and companies. WHEN: Thursday, April 29

12:00 Noon -- 2:00 PM WHERE: National Press Club

First Amendment Room

529 14th Street, N.W.

Washington, D.C. WHO: Dr. Anthony H. Wild, President, Pharmaceutical Sector,

Warner-Lambert Company Arnon A. Mishkin, Vice

President, Boston Consulting Group Simon J. Goodall,

Project Leader, Boston Consulting Group WHY: In Japan, the U.S. and several countries in Europe,

debate continues to rage over health care reform. This

important study will provide valuable information and

analysis for those policy debates. RSVP TO: Lisa Knapp -- 202-548-0602 Editors Note: A Video News Release and copies of the studywill be available. Following their presentations, theparticipants will be available to answer questions. ots OriginalText Service: Warner-Lambert Company Internet:http://www.newsaktuell.de CONTACT: Steve Selby, 202-548-0601,for Warner-Lambert Company.

Subscribers please note that material bearing the slug"PROTEXT" is not part of CTK's news service and is not to bepublished under the "CTK" slug. Protext is a commercial serviceproviding distribution of press releases from clients, who areidentified in the text of Protext reports and who bear fullresponsibility for their contents.

PROTEXT